MYND.AI INC (MYND) Stock Fundamental Analysis

USA • NYSE Arca • NYSEARCA:MYND • US6289881079

0.5096 USD

+0.01 (+2.95%)

Last: Feb 2, 2026, 12:45 PM

Fundamental Rating

MYND gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 76 industry peers in the Diversified Consumer Services industry. Both the profitability and financial health of MYND have multiple concerns. MYND is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

MYND had negative earnings in the past year.
In the past year MYND has reported a negative cash flow from operations.
In the past 5 years MYND reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: MYND reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of MYND (-59.40%) is worse than 82.89% of its industry peers.
MYND has a worse Return On Equity (-2139.61%) than 82.89% of its industry peers.

		Industry Rank	Sector Rank
ROA	-59.4%
ROE	-2139.61%
ROIC	N/A

ROA(3y)-32.96%

ROA(5y)-21.76%

ROE(3y)-180.35%

ROE(5y)-118.21%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 24.01%, MYND is doing worse than 72.37% of the companies in the same industry.
In the last couple of years the Gross Margin of MYND has grown nicely.
The Profit Margin and Operating Margin are not available for MYND so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	24.01%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y72.61%

GM growth 5Y11.08%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MYND does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MYND has less shares outstanding
Compared to 5 years ago, MYND has more shares outstanding
The debt/assets ratio for MYND is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -2.43, we must say that MYND is in the distress zone and has some risk of bankruptcy.
MYND has a worse Altman-Z score (-2.43) than 72.37% of its industry peers.
A Debt/Equity ratio of 10.08 is on the high side and indicates that MYND has dependencies on debt financing.
MYND has a Debt to Equity ratio of 10.08. This is amonst the worse of the industry: MYND underperforms 82.89% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	10.08
Debt/FCF	N/A
Altman-Z	-2.43

ROIC/WACCN/A

WACC7.1%

2.3 Liquidity

MYND has a Current Ratio of 0.94. This is a bad value and indicates that MYND is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.94, MYND is not doing good in the industry: 60.53% of the companies in the same industry are doing better.
A Quick Ratio of 0.69 indicates that MYND may have some problems paying its short term obligations.
The Quick ratio of MYND (0.69) is worse than 73.68% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.94
Quick Ratio	0.69

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for MYND have decreased strongly by -50.59% in the last year.
MYND shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -36.15%.
The Revenue has been growing slightly by 7.96% on average over the past years.

EPS 1Y (TTM)-50.59%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%38.76%

Revenue 1Y (TTM)-36.15%

Revenue growth 3Y72.71%

Revenue growth 5Y7.96%

Sales Q2Q%-39.21%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.